Table 2.
Advantages and disadvantages of the different CRRT modalities, as well as its alternatives iHD and PD
| Technique | Physical principle | Minimum duration (hours) | Advantages | Disadvantages |
|---|---|---|---|---|
| PD | Diffusion | 24 |
• Technically, the simplest modality • Require less infrastructure and lower costs • No need for anticoagulation • Possible in hemodynamically unstable patients |
• Slow small molecule and uremic toxin clearance • Less predictable fluid removal • Risk of infections (e.g., peritonitis) • Not possible if recent abdominal surgery • May have impact on respiratory stability |
| IHD | Diffusion | 4–6 |
• Rapid removal of toxins, electrolytes and fluid overload • Minimal/no need for anticoagulation • Relatively lower cost than the techniques below • Less restrictions on patients mobility |
• Not recommended in critically ill hemodynamically unstable patients • Increased risk of hypotension and electrolytes disequilibrium • Require vascular access • Technically expertise required • Clearance rebound |
| PIRRT/SLED | Diffusion | 6–12 |
• More rapid solutes removal than CRRT, but slower than IHD • More hemodynamically stable than IHD • Technically simpler than the techniques below • Relatively lower cost (e.g., less bags needed) • More restrictions on patients mobility than IHD but less than the techniques below |
• Not recommended in critically ill hemodynamically unstable patients • Require vascular access and anticoagulant • Risks of hypotension and disequilibrium • Lower efficiency than other modalities |
| CVVH | Convection & ultrafiltration | 24 |
• Convection allows highly efficient middle molecule and cytokine removal • Continuous removal of uremic toxins and fluid • Possible use in hemodynamic unstable patients |
• Technically complex (e.g., complex circuit and high cost) • Require vascular access and anticoagulant (systemic or regional) • Need patient immobility • Prolonged exposure to membranes • Less efficient for small molecule removal than IHD |
| CVVHD | Diffusion & ultrafiltration | 24 |
• Continuous removal of uremic toxins and fluid • Possible use in hemodynamic unstable patients • Better removal of small molecules than CVVH |
• Technically complex (e.g., complex circuit and high cost) • Require vascular access and anticoagulant (systemic or regional) • Need patient immobility • Prolonged exposure to membranes • Less efficient for small molecule removal than IHD |
| CVVHDF | Diffusion, convection & ultrafiltration | 24 |
• Convection allows highly efficient middle molecule and cytokine removal • Continuous removal of uremic toxins and fluid • Possible use in hemodynamic unstable patients • Better removal of small molecules than CVVH |
• Technically most complex CRRT modality (e.g., complex circuit with frequent bag changes and high cost) • Require vascular access and anticoagulant (systemic or regional) • Need patient immobility • Prolonged exposure to membranes • Less efficient for small molecule removal than IHD |
PD peritoneal dialysis, IHD intermittent hemodialysis, PIRRT prolonged intermittent renal replacement therapy, SLED slow low efficiency dialysis, CVVH continuous venovenous hemofiltration, CVVHD continuous venovenous hemodialysis, CVVHDF continuous venovenous hemodiafiltration